Internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations in the FLT3 gene are some of the most common mutations in patients with newly diagnosed acute myeloid leukemia (AML). This evidence concerns the gene FLT3 and acute myeloid leukemia.